Nuzenio

Actio Bioscience Acquisition

Actio Bioscience Acquisition news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 16 latest news signals 15 publisher sources 100/100 entity strength

Latest news

$1.32 Billion for a Molecule: Jazz Pharmaceuticals Bets on Rare-Epilepsy Drug With No Approved Rivals - USA HeraldUSA Herald · Mon, 10 Aug 2026 19:01:18 GMTJazz Pharmaceuticals: Buy Rating Reiterated as Actio Bioscience Acquisition and ABS-1230 Growth Potential Support Unchanged $307 Price Target - TipRanksTipRanks · Mon, 10 Aug 2026 17:29:04 GMTJazz Pharmaceuticals to acquire San Diego biotech for up to $1.3B - The Business JournalsThe Business Journals · Mon, 10 Aug 2026 17:14:00 GMTJazz Pharmaceuticals expands rare epilepsy pipeline with Actio Biosciences deal - European Pharmaceutical ReviewEuropean Pharmaceutical Review · Mon, 10 Aug 2026 16:17:36 GMTJazz bets on epilepsy treatment with up to $1.32 billion deal for Actio - ReutersReuters · Mon, 10 Aug 2026 15:11:12 GMTJazz pays $820M to buy Actio, adding clinical-stage asset to orchestra of epilepsy therapies - Fierce BiotechFierce Biotech · Mon, 10 Aug 2026 14:40:00 GMTJAZZ Looks 70.7% Overvalued on GF Value™ Amid $820M Actio Biosciences Acquisition - GuruFocusGuruFocus · Mon, 10 Aug 2026 14:30:32 GMTJazz Pharmaceuticals to Acquire Actio Biosciences for $1.32 Billion - pharmexec.compharmexec.com · Mon, 10 Aug 2026 14:22:59 GMT

Timeline

Mon, 10 Aug 2026 19:01:18 GMT$1.32 Billion for a Molecule: Jazz Pharmaceuticals Bets on Rare-Epilepsy Drug With No Approved Rivals - USA Herald
Mon, 10 Aug 2026 17:29:04 GMTJazz Pharmaceuticals: Buy Rating Reiterated as Actio Bioscience Acquisition and ABS-1230 Growth Potential Support Unchanged $307 Price Target - TipRanks
Mon, 10 Aug 2026 17:14:00 GMTJazz Pharmaceuticals to acquire San Diego biotech for up to $1.3B - The Business Journals
Mon, 10 Aug 2026 16:17:36 GMTJazz Pharmaceuticals expands rare epilepsy pipeline with Actio Biosciences deal - European Pharmaceutical Review
Mon, 10 Aug 2026 15:11:12 GMTJazz bets on epilepsy treatment with up to $1.32 billion deal for Actio - Reuters
Mon, 10 Aug 2026 14:40:00 GMTJazz pays $820M to buy Actio, adding clinical-stage asset to orchestra of epilepsy therapies - Fierce Biotech

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Actio Bioscience Acquisition.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

15 distinct publisher/source names are currently connected to this entity page.